The efficacy of combination therapy using adeno-associated virus-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma

Tumor Biology

Volumn 34, Issue 5, 2013, Pages 3027-3034

  Yuan, Lijie ^a,b   Zhao, Hengyu ^c   Zhang, Liqiu ^a   Liu, Xinghan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b State Province Key Laboratories of Biomedicine Pharmaceutics of China   (China)

^c DAQING OILFIELD CO LTD   (China)

Author keywords

AAV; Apoptin; Apoptosis; Hepatocarcinoma; IL 24

Indexed keywords

EID: 84885430641     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0867-z     Document Type: Article

References (17)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. Roberts LR. Sorafenib in liver cancer - just the beginning. N Engl J Med. 2008;359:420-2.
3. Roayaie S, Blume IN, Thung SN, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137:850-5.
4. Newell P, Villanueva A, Llovet JM. Molecular targeted therapies in hepatocellular carcinoma: from pre-clinical models to clinical trials. J Hepatol. 2008;49:1-5.
5. Yang CL, Jiang FQ, Xu F, Jiang GX. ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma. Tumour Biol. 2012;33:1535-41.
6. Kaliberova LN, Krendelchtchikova V, Harmon DK, et al. CRAdRGDflt-IL-24 virotherapy in combination with chemotherapy of experimental glioma. Cancer Gene Ther. 2009;16:794-805.
7. Zerbini LF, Tamura RE, Correa RG, et al. Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-kappaB inhibitors in ovarian cancer therapy. PLoS One. 2011;6:e24285.
8. Patani N, Douglas-Jones A, Mansel R, et al. Tumour suppressor function of MDA-7/IL-24 in human breast cancer. Cancer Cell Int. 2010;10:29.
9. Zhu Y, Lv H, Xie Y, et al. Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells. Cancer Gene Ther. 2011;18:627-36.
10. Yan S, Zhang H, Xie Y, et al. Recombinant human interleukin-24 suppresses gastric carcinoma cell growth in vitro and in vivo. Cancer Investig. 2010;28:85-93.
11. Lebedeva IV, Su ZZ, Sarkar D, et al. Melanoma differentiation associated gene-7, mda-7/interleukin-24, induces apoptosis in prostate cancer cells by promoting mitochondrial dysfunction and inducing reactive oxygen species. Cancer Res. 2003;63:8138-44.
12. Los M, Panigrahi S, Rashedi I, et al. Apoptin, a tumor-selective killer. Biochim Biophys Acta. 2009;1793:1335-42.
13. Yuan L, Zhang L, Dong X, Zhao H, Li S, Han D, et al. Apoptin selectively induces the apoptosis of tumor cells by suppressing the transcription of HSP70. Tumour Biol. 2013;34:577-85.
14. Lin B, Kolluri SK, Lin F, et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell. 2004;116:527-40.
15. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70.
16. Jiang G, Jiang AJ, Cheng Q, et al. A dual-regulated oncolytic adenovirus expressing interleukin-24 sensitizes melanoma cells to temozolomide via the induction of apoptosis. Tumour Biol. 2013;34:1263-71.
17. Yacoub A, Park MA, Gupta P, et al. Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells. Mol Cancer Ther. 2008;7:297-313.